Skip to main content

Table 3 Causes of death

From: Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors

 

Group I (4 × 3.8 Gy)

Group II (2 × 7.2 Gy)

Fatal hemoptysis

18.3%

12.2%

Other reason than tumor progression

13.3%

8.5%

Local problems

20%

32.9%

Unknown

15%

12.2%